Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).

被引：0
|
作者：
de la Fuente, J
Richards, S
Webb, DK
Hann, IM
Mitchell, CD
Vora, AJ
Kinsey, SE
Eden, OB
Ancliff, P
机构：
[1] Great Ormond St Hosp Children, Dept Haematol, London WC1N 3JH, England
[2] CTSU, Oxford, England
[3] John Radcliffe Hosp, Oxford OX3 9DU, England
[4] Sheffield Childrens Hosp, Dept Haematol, Sheffield S10 2TH, S Yorkshire, England
[5] St James Univ Hosp, Dept Paediat Oncol, Leeds LS9 7TF, W Yorkshire, England
[6] Christie Hosp, Acad Unit Paediat Oncol, Manchester, Lancs, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
873
引用
收藏
页码：256A / 257A
页数：2
相关论文
共 50 条
  • [31] Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group
    Maloney, Kelly W.
    Carroll, William L.
    Carroll, Andrew J.
    Devidas, Meenakshi
    Borowitz, Michael J.
    Martin, Paul L.
    Pullen, Jeanette
    Whitlock, James A.
    Willman, Cheryl L.
    Winick, Naomi J.
    Camitta, Bruce M.
    Hunger, Stephen P.
    BLOOD, 2010, 116 (07) : 1045 - 1050
  • [32] Down syndrome (DS) patients with intermediate risk (IR) acute lymphoblastic leukemia (ALL): Events and outcome on children's cancer group (CCG) 1891 study.
    Franklin, J
    Larsen, S
    Dorey, F
    Butturini, A
    Fu, C
    Lange, B
    Sather, H
    Gaynon, P
    BLOOD, 2004, 104 (11) : 541A - 541A
  • [33] Molecular Response to Treatment Predicts Outcome in Isolated, but Not in Combined Bone Marrow Relapses of Childhood Acute Lymphoblastic Leukaemia: Interim Results of Trial ALL-REZ BFM 2002.
    Eckert, Cornelia
    Stackelberg, Arend
    Hagedorn, Nikola
    Barth, Andrea
    Seeger, Karl
    Henze, Guenter
    BLOOD, 2008, 112 (11) : 873 - 873
  • [34] Post-Remission MRD Kinetics in Children with Acute Lymphoblastic Leukaemia Receiving Augmented BFM Consolidation Compared with Other Regimens Results of the Medical Research Council Trial UKALL2003.
    Cutting, Robert J.
    Richards, Sue
    Hancock, Jeremy
    Goulden, Nicholas
    Mitchell, Christopher D.
    Vora, Ajay J.
    BLOOD, 2008, 112 (11) : 539 - 540
  • [35] Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).
    Rowe, JM
    Richards, SM
    Burnett, AK
    Wiernik, PH
    Harrison, G
    Lazarus, HM
    Franklin, IM
    Prentice, GH
    Durrant, JI
    Tallman, MS
    Goldstone, AH
    BLOOD, 2001, 98 (11) : 481A - 481A
  • [36] Post-remission MRD kinetics in children with acute lymphoblastic leukaemia receiving augmented BFM consolidation compared with other regimens: update of results of the Medical Research Council Trial UKALL2003
    Cutting, R. J.
    Richards, S.
    Hancock, J.
    Goulden, N.
    Mitchell, C. D.
    Vora, A. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 46 - 47
  • [37] Preliminary Outcomes of Children and Young Adults with Acute Lymphoblastic Leukaemia and Down Syndrome (DS-ALL) on UKALL 2011. Reduction in Treatment-Related Mortality with De-Escalated Therapy
    Ghorashian, Sara
    Samarasinghe, Sujith
    Kirkwood, Amy A.
    Hough, Rachael
    Rowntree, Clare
    Lawson, Sarah
    Goulden, Nicholas John
    Pond, Emma
    Kearns, Pamela R.
    Moorman, Anthony V.
    Moppett, John
    Vora, Ajay
    BLOOD, 2018, 132
  • [38] Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocols 00-001 and 05-001
    Athale, Uma H.
    Puligandla, Maneka
    Stevenson, Kristen E.
    Asselin, Barbara L.
    Clavell, Luis A.
    Cole, Peter D.
    Kelly, Kara M.
    Laverdiere, Caroline
    Leclerc, Jean-Marie
    Michon, Bruno
    Schorin, Marshall A.
    Sulis, Maria Luisa
    Welch, Jennifer J. G.
    Harris, Marian H.
    Neuberg, Donna S.
    Sallan, Stephen E.
    Silverman, Lewis B.
    BLOOD, 2016, 128 (22)
  • [39] Dietary Antioxidant Micronutrient Intake and Toxicity during Remission Induction in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001
    Kelly, Kara M.
    Ladas, Elena
    Blonquist, Traci M.
    Stevenson, Kristen E.
    Lin, Meiko
    Cole, Peter D.
    Orjuela, Manuela
    Athale, Uma
    Clavell, Luis A.
    Laverdiere, Caroline
    Leclerc, Jean-Marie
    Michon, Bruno
    Schorin, Marshall A.
    Sulis, Maria Luisa
    Welch, Jennifer J. G.
    Asselin, Barbara L.
    Sallan, Stephen E.
    Silverman, Lewis B.
    BLOOD, 2017, 130
  • [40] Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172)
    Hill, FGH
    Richards, S
    Gibson, B
    Hann, I
    Lilleyman, J
    Kinsey, S
    Mitchell, C
    Harrison, CJ
    Eden, OB
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) : 33 - 46
12345